within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01M_QuinoloneAntibacterials.J01MA03_Pefloxacin;

model Pefloxacin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.92,
    Cl = 1.25e-06,
    adminDuration = 600,
    adminMass = 400 / 1000000,
    adminCount = 1,
    Vd = 0.002,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.014666666666666666,
    Tlag = 10.200000000000001,
    Vdp = 0.057,
    k12 = 8.527777777777779e-06,
    k21 = 8.527777777777779e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Pefloxacin</td></tr><tr><td>ATC code:</td><td>J01MA03</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>400</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>2.0</td><td>L</td></tr>
    <tr><td>clearance:</td><td>4.5</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Pefloxacin is a synthetic broad-spectrum fluoroquinolone antibiotic formerly used for the treatment of various bacterial infections, including urinary and respiratory tract infections. It is not widely approved or used in many countries today due to safety concerns, particularly related to tendon damage and CNS effects.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Bulitta, JB, et al., &amp; Sörgel, F (2019). Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. <i>Pharmaceutics</i> 11(7) –. DOI:<a href=\"https://doi.org/10.3390/pharmaceutics11070323\">10.3390/pharmaceutics11070323</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31295857/\">https://pubmed.ncbi.nlm.nih.gov/31295857</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J01MA03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Pefloxacin;
